Max Pihlqvist

Max Pihlqvist serves as CEO at LABEX OF SCANDINAVIA. LABEX OF SCANDINAVIA operates in the medical devices sector with approximately 32.0 employees. The company is headquartered in Stockholm, Stockholm County.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 2,710 executive contacts are available in Stockholm County.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 reCAPTCHA WordPress.org Mobile Friendly Typekit Google Tag Manager Hotjar

frystorkning vakuumcentrifugering centrifugering osmolalitet transfusionsmedicin serologi immunohematologi healthcare freeze drying life science immunohematology clinical microbiology hla typing blood transfusion coagulation bioprocess quality control automation centrifugation lyophilization cryometry osmolality safety & purity diagnostic solutions innovative products customer support long-term relationships iso 9001 iso 14001 ce marked products supply chain management product development research & development clinical diagnostics patient near analysis hematology reagents blood grouping antibody screening pcr technology bioanalysis laboratory equipment cell counting quality assurance sustainable practices market trends technical support niche products training & education turnkey solutions reagent systems automated strip cutter blood products performance testing test cell controls suspension solutions clinical trials innovative solutions medication development health care health wellness & fitness hospital & health care logistics & supply chain

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Max Pihlqvist in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at LABEX OF SCANDINAVIA.

Max Pihlqvist's Position in the MessageCEO Database

• •Max Pihlqvist is 1 of 1 verified executive contact we track at LABEX OF SCANDINAVIA.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •2,690 verified executive contacts in Stockholm County are in the database.
• •25 verified contacts work at medical devices companies in the 32.0 employee range (same size as LABEX OF SCANDINAVIA).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Max Pihlqvist directly?

Max Pihlqvist's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at LABEX OF SCANDINAVIA. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Max Pihlqvist work for?

Max Pihlqvist is CEO at LABEX OF SCANDINAVIA, a company in the medical devices sector with 32.0 employees. The company is based in Stockholm, Stockholm County.

Can I pitch or sell to Max Pihlqvist?

As CEO at LABEX OF SCANDINAVIA, Max Pihlqvist is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Max Pihlqvist directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Max Pihlqvist in?

Max Pihlqvist works in the medical devices industry as CEO at LABEX OF SCANDINAVIA. MessageCEO provides verified contact information for executives across all major industries.

Is Max Pihlqvist's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Max Pihlqvist's profile is kept up-to-date with the latest available information.

Last updated: July 18, 2026